- Home
- WFCF vs ABOS Comparison
WFCF vs ABOS Comparison
Compare WFCF & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFCF
- ABOS
- Stock Information
- Founded
- WFCF 1996
- ABOS 1996
- Country
- WFCF United States
- ABOS United States
- Employees
- WFCF N/A
- ABOS N/A
- Industry
- WFCF Computer Software: Prepackaged Software
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- WFCF Technology
- ABOS Health Care
- Exchange
- WFCF Nasdaq
- ABOS Nasdaq
- Market Cap
- WFCF 60.7M
- ABOS 66.6M
- IPO Year
- WFCF 2011
- ABOS 2021
- Fundamental
- Price
- WFCF $10.38
- ABOS $1.02
- Analyst Decision
- WFCF
- ABOS Strong Buy
- Analyst Count
- WFCF 0
- ABOS 3
- Target Price
- WFCF N/A
- ABOS $7.33
- AVG Volume (30 Days)
- WFCF 1.6K
- ABOS 184.4K
- Earning Date
- WFCF 05-08-2025
- ABOS 05-13-2025
- Dividend Yield
- WFCF N/A
- ABOS N/A
- EPS Growth
- WFCF N/A
- ABOS N/A
- EPS
- WFCF 0.38
- ABOS N/A
- Revenue
- WFCF $25,437,000.00
- ABOS N/A
- Revenue This Year
- WFCF N/A
- ABOS N/A
- Revenue Next Year
- WFCF N/A
- ABOS N/A
- P/E Ratio
- WFCF $27.63
- ABOS N/A
- Revenue Growth
- WFCF N/A
- ABOS N/A
- 52 Week Low
- WFCF $9.26
- ABOS $0.86
- 52 Week High
- WFCF $13.50
- ABOS $3.61
- Technical
- Relative Strength Index (RSI)
- WFCF 46.95
- ABOS 46.66
- Support Level
- WFCF $9.26
- ABOS $0.97
- Resistance Level
- WFCF $11.26
- ABOS $1.09
- Average True Range (ATR)
- WFCF 0.24
- ABOS 0.06
- MACD
- WFCF 0.01
- ABOS 0.00
- Stochastic Oscillator
- WFCF 56.15
- ABOS 46.56
About WFCF Where Food Comes From Inc.
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.